Business Wire

European 100 Study Reveals: Despite Year-over-Year Improvements, Tremendous Opportunity to Enhance Hiring with AI, Automation and Experience Remains

1.6.2023 12:00:00 EEST | Business Wire | Press release

Share

Phenom released the second annual European Edition of its State of Candidate Experience Report, revealing significant improvement in the use of AI over one year and shining a spotlight on enormous opportunities for companies to enhance job seekers’ experiences through intelligence and automation.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230601005156/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

‘State of Candidate Experience: 2023 Benchmarks Report — European Edition’ reveals, despite year-over-year improvements, tremendous opportunity to enhance hiring with AI, automation and experience remains. The second annual report provides recommendations, including small steps for making big impacts. (Photo: Business Wire)

Phenom audited the top 100 European companies of the Global 500 list in three key areas of the talent journey: attraction, engagement and conversion, as well as the use of AI. By viewing their strengths, weaknesses and opportunities for improvement, HR leaders, talent acquisition teams and hiring managers can gain valuable insights and best practices to improve the candidate experience, grow quality talent pools faster and hire more efficiently.

The 2023 audit of European 100 career sites reveals improvement year-over-year to deliver hyper-personalized experiences and job matching that strengthen candidate attraction, engagement and conversion, including a:

  • 525% increase in presenting job recommendations based on browsing history
  • 67% increase in using a recruitment chatbot
  • 64% increase in showing job recommendations based on geographic location
  • 60% increase in displaying recently viewed jobs

Although organizations are increasingly adopting AI-powered technology to improve experiences, 94% scored poorly in their use of AI, indicating there is still a significant gap between the solutions available and what companies have implemented. According to the 2023 audit:

  • 90% did not use a recruitment chatbot
  • 83% did not display recently viewed jobs
  • 82% did not share job recommendations based on geographic location
  • 75% did not present job recommendations based on browsing history

“Enhancing the candidate experience is a critical step in attracting the right qualified talent in this highly competitive market,” said Mahe Bayireddi, CEO and co-founder of Phenom. “Providing phenomenal, personalized experiences for job seekers is only possible through intelligence and automation.”

The ROI of Intelligence, Automation and Experience

Although retaining employees has become a primary goal for European companies, proactively improving the candidate experience remains an imperative. Organisations are struggling to fill open positions amidst economic challenges including an energy crisis, inflation and an ultra-competitive talent market.

To outpace competitors, employers must embrace cutting-edge practices and AI technology for hiring, developing and retaining talent. Intelligence, automation and experience are essential to overcoming today’s biggest talent acquisition and retention challenges, including simplifying the job search process and maintaining an attractive, unique employer brand. Hyper-personalized career sites, conversational chatbots, automated screening and scheduling, and content that showcases a company’s culture all enrich the candidate experience, helping them find the right job faster and apply.

Savvy organisations that are leveraging AI-powered technology and automation through the Phenom Intelligent Talent Experience platform are attracting more best-fit job seekers, growing talent communities and increasing completed applications, and the results speak for themselves:

  • A major telecommunications company increased career site traffic by 220% and increased completed applications by 700% with intelligent tools that provided a more personalized experience for candidates
  • A large health care organisation achieved a 10% increase in nursing hires by expediting communication with candidates through a conversational chatbot and SMS messages
  • A leading financial institution added 8X more candidates to their talent community by creating a dynamic, hyper-personalized career site and targeting recruitment marketing efforts
  • A popular restaurant chain registered over 12,000 candidates through their career site and talent email campaigns in less than a month — resulting in more than 2,000 same-day offers to candidates and 1,300+ same-week hires

Actions Organisations Can Take to Accelerate Hiring

To improve the candidate experience, Phenom’s European Edition of its State of Candidate Experience Report prescribes a series of actions organisations can take — from creating strong employer brand content to implementing intelligent technology on its career site:

  • Personalize the candidate experience through AI and automation. Candidates today expect the online job search to be similar to purchasing consumer goods, where relevant information is delivered based on their interests. If this process isn’t intuitive and simple, they are more likely to drop off a career site. With AI and automation on a career site, personalized jobs and content automatically displayed for candidates based on their resume, experience, skills, and geographic location.
  • Showcase a strong employer brand through content. When deciding if a job is the right fit for them, candidates spend a significant amount of time researching a company. If your digital brand doesn’t meet their expectations, they may not feel a strong connection and apply to an open role. Content on a career site (videos, pictures, blogs, etc.) that conveys information such as your company’s mission and purpose, overall workplace culture, employee quotes and stories, internal events and employee resource groups all paint a picture of what it’s like to work there.
  • Embrace cutting-edge technology. In addition to AI and automation, organizations must be quick to adopt work-altering innovations, such as: generative AI — which enables organisations to reach previously unattainable levels of productivity and fill roles faster by automatically creating content, surfacing actionable intelligence, and eliminating time-consuming tasks; interview intelligence, which brings transparency to hiring teams through recordings, transcriptions, key takeaway, and analysis to move the process forward faster; and candidate hub, a one-stop-shop that helps candidates understand where they are in the hiring process and prepare for next steps.

With Phenom, candidates find and choose the right job faster, employees develop their skills and evolve, recruiters become wildly productive, managers build stronger-performing teams, HR aligns employee development with company goals, and HRIS easily integrates existing HR tech to create a holistic infrastructure.

To read the full State of Candidate Experience: 2023 Benchmarks Report — European Edition and company rankings, download here.

About Phenom

Phenom has a purpose of helping a billion people find the right job. Through AI-powered talent experiences, employers are using Phenom to hire employees faster, develop them to their full potential, and retain them longer. The Phenom Intelligent Talent Experience platform seamlessly connects candidates, employees, recruiters, hiring managers, HR and HRIS — empowering over 500 diverse and global enterprises with innovative products including Phenom Career Site, Chatbot, CMS, CRM, AI Scheduling, Video Assessments, Campaigns, University Recruiting, Talent Marketplace, Career Pathing, Gigs, Mentoring, and Referrals.

Phenom has earned accolades including: Inc. 5000’s fastest-growing companies (3 consecutive years), Deloitte Technology's Fast 500 (4 consecutive years), five Brandon Hall ‘Excellence in Technology’ awards including Gold for ‘Best Advance in AI for Business Impact,’ Business Intelligence Group's Artificial Intelligence Excellence Awards (3 consecutive years), and a regional Timmy Award for launching and optimizing HelpOneBillion.com (2020).

Headquartered in Greater Philadelphia, Phenom also has offices in India, Israel, the Netherlands, Germany and the United Kingdom.

For more information, please visit www.phenom.com. Connect with Phenom on LinkedIn, Twitter, Facebook, YouTube and Instagram.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Media:
Jennifer Lyons
Director, Global Communications
267-379-5066
jennifer.lyons@phenompeople.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Backed by Investments Exceeding $1 Billion, PCI Pharma Services Announces Major Expansion of US Sterile Fill-Finish and Drug-Device Delivery Combination Capabilities27.4.2026 17:00:00 EEST | Press release

PCI Pharma Services (“PCI”) – a world-leading integrated global contract development and manufacturing organization (CDMO) focused on innovative biologic and small molecule therapies – announced a series of major infrastructure investments that substantially deepen its sterile fill-finish and advanced drug delivery capabilities. As pharma manufacturers and their development partners increasingly prioritize US supply chain resilience, PCI’s latest investments come as part of a broader commitment exceeding $1 billion across the CDMO’s US and European operations, reinforcing its ability to provide seamless support for drug product development and manufacturing, clinical trial supply and drug-device combination assembly from clinical stages through commercial launch – all underpinned by global capacity, technical expertise, deep scientific knowledge, and an industry-leading quality and regulatory track record. This press release features multimedia. View the full release here: https://www.

Pure Lithium Appoints Renowned Battery Expert Dr. Yuan Gao to Board of Directors27.4.2026 16:53:00 EEST | Press release

Pure Lithium Corporation, a vertically integrated lithium metal battery technology company, is pleased to announce that world-renowned inventor and battery expert Dr. Yuan Gao has joined the company’s Board of Directors. Dr. Gao has been an invaluable member of Pure Lithium’s Scientific Advisory Board since October of 2023. "We are thrilled to have Dr. Gao join our board as we focus on rapidly scaling our technology in the most capital efficient manner possible,” said Pure Lithium Founder, Chairman and CEO Emilie Bodoin. “Dr. Gao is a brilliant scientist who also has deep commercial expertise, a rare combination. He is also unique in the industry because his experience spans the entire battery materials value chain, including all of Pure Lithium’s verticals. His insights over the years have been critical in advancing our technology, and his experience as a director of public companies will strengthen our board.” Dr. Gao commented: “I am thrilled to join the board of Pure Lithium Corpor

Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 202627.4.2026 16:00:00 EEST | Press release

Boomi, the data activation company, today announced Boomi World 2026, its premier annual user conference, taking place May 11 - 14, 2026 in Chicago, IL. The event will bring together customers, partners, and industry leaders from around the world to explore how data activation is transforming the enterprise and accelerating the path to AI-driven outcomes. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427600340/en/ Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 2026 Boomi World 2026 will spotlight data activation — bringing data to life to power AI, analytics, and intelligent automation. Attendees will gain firsthand insights into how the Boomi Enterprise Platform enables businesses to unify data, streamline operations, and innovate faster in an increasingly agentic world. “Data is only valuable when it’s activated,” said Steve Lucas, Chairman and CEO, Boomi. “At Boomi World 2026, we

Axinn Appoints Rachael Philbin as Chief Innovation Officer27.4.2026 16:00:00 EEST | Press release

Axinn, Veltrop & Harkrider LLP today announced the appointment of Rachael Philbin as Chief Innovation Officer, reinforcing the firm’s continued investment in advanced solutions and technology for legal services delivery. Philbin joins from Proskauer Rose LLP, where she served as Innovation & Transformation Officer. Based in Axinn's New York office, she will lead the firm’s AI and legal technology initiatives as well as knowledge management efforts, accelerating adoption and integration across its antitrust, intellectual property, and litigation practices. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427277725/en/ Rachael Philbin joins Axinn, Veltrop & Harkrider LLP as Chief Innovation Officer. “As Axinn continues to grow, we are making deliberate investments in the capabilities that enable our lawyers to deliver service and results at the highest level in our clients’ complex matters,” said Jeny Maier, managing partner

Taiho Oncology, Taiho Pharmaceutical and Araris Biotech AG Advance ADC ARC-02 into Phase 1 Clinical Development27.4.2026 16:00:00 EEST | Press release

Taiho Oncology, Inc., Taiho Pharmaceutical Co., Ltd., and Araris Biotech AG (“Araris”) today announced that the U.S. Food and Drug Administration (FDA) has completed its Investigational New Drug (IND) review period for ARC-02, an antibody-drug conjugate (ADC) being developed for the treatment of non-Hodgkin lymphoma, enabling Taiho Oncology to initiate a Phase 1 dose-escalation clinical trial of ARC-02. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427127507/en/ Taiho Pharmaceutical acquired Araris Biotech in March 2025, expanding Taiho group’s capabilities in biologics and ADC research and development. Araris is a spin-off of the Paul Scherrer Institute and ETH in Switzerland focused on the development of antibody-drug conjugates (ADCs). Central to Araris’ approach is its proprietary AraLinQ™ ADC technology, which enables the creation of stable and site-specific ADCs using standard antibodies with scalable manufacturing

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye